Pfizer | PFE - Pre Tax Profit



Pfizer reported $3.04B in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
AbbVie USD 1.66B 3.15B Mar/2025
Abbott USD 2.15B 372M Jun/2025
ALKERMES USD 104.84M 79.35M Jun/2025
Amgen USD 1.57B 405M Jun/2025
AstraZeneca USD 3.13B 275M Jun/2025
Bayer EUR -426000000 2.26B Jun/2025
Biogen USD 744M 432.8M Jun/2025
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Drreddys Laboratories 19.05B 304M Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
Glaxosmithkline USD 1.89B 230.76M Jun/2025
J&J USD 13.63B 8.21B Mar/2025
Medtronic USD 1.87B 612M Jul/2025
Merck USD 6.77B 864M Jun/2025
Neurocrine Biosciences USD 159.5M 144.8M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Novartis USD 4.53B 133M Jun/2025
Pacira USD -1927000 10.63M Jun/2025
Perrigo USD 3.2M 5.1M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Prestige Brands USD 61.78M 12.18M Jun/2025
Regeneron Pharmaceuticals USD 1.52B 613.7M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Sanofi EUR 1.42B 734M Jun/2025
Sanofi USD 1.47B 855.43M Jun/2025
Vertex Pharmaceuticals USD 1.28B 552.6M Jun/2025
Zoetis USD 902M 92M Jun/2025